NYSE - Delayed Quote USD

Quest Diagnostics Incorporated (DGX)

Compare
155.48 +0.10 (+0.06%)
At close: 4:00 PM EDT
155.48 0.00 (0.00%)
After hours: 5:26 PM EDT
Loading Chart for DGX
DELL
  • Previous Close 155.38
  • Open 155.20
  • Bid 149.95 x 800
  • Ask 155.78 x 900
  • Day's Range 155.10 - 157.06
  • 52 Week Range 119.59 - 159.36
  • Volume 440,170
  • Avg. Volume 844,943
  • Market Cap (intraday) 17.308B
  • Beta (5Y Monthly) 0.89
  • PE Ratio (TTM) 20.98
  • EPS (TTM) 7.41
  • Earnings Date Oct 22, 2024 - Oct 28, 2024
  • Forward Dividend & Yield 3.00 (1.93%)
  • Ex-Dividend Date Oct 4, 2024
  • 1y Target Est 155.05

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

www.questdiagnostics.com

50,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: DGX

View More

Performance Overview: DGX

Trailing total returns as of 9/18/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

DGX
14.62%
S&P 500
17.79%

1-Year Return

DGX
25.94%
S&P 500
26.24%

3-Year Return

DGX
6.73%
S&P 500
26.74%

5-Year Return

DGX
62.03%
S&P 500
86.92%

Compare To: DGX

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: DGX

View More

Valuation Measures

Annual
As of 9/17/2024
  • Market Cap

    17.30B

  • Enterprise Value

    22.11B

  • Trailing P/E

    20.97

  • Forward P/E

    16.13

  • PEG Ratio (5yr expected)

    1.61

  • Price/Sales (ttm)

    1.86

  • Price/Book (mrq)

    2.61

  • Enterprise Value/Revenue

    2.37

  • Enterprise Value/EBITDA

    12.62

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    8.99%

  • Return on Assets (ttm)

    6.13%

  • Return on Equity (ttm)

    13.59%

  • Revenue (ttm)

    9.35B

  • Net Income Avi to Common (ttm)

    836M

  • Diluted EPS (ttm)

    7.41

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    271M

  • Total Debt/Equity (mrq)

    75.55%

  • Levered Free Cash Flow (ttm)

    787.88M

Research Analysis: DGX

View More

Company Insights: DGX

Research Reports: DGX

View More

People Also Watch